Print

Moberg Pharma AB (Formerly known as Moberg Derma) Interim Report January – March 2013  
5/21/2013 7:44:13 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Regulatory News:

Moberg Pharma AB (publ) (STO:MOB)

Continued Strong Growth - Moberg Derma Becomes Moberg Pharma

FIRST QUARTER (JAN-MAR 2013)

•Revenue MSEK 38.4 (31.0 including milestone payments of MSEK 14.3)

Help employers find you! Check out all the jobs and post your resume.

//-->